Immature anti-inflammatory response in neonates

Clinical and Experimental Immunology

Volumn 135, Issue 1, 2004, Pages 130-136

  Schultz, C ^a   Temming, P ^a   Bucsky, P ^a   Gopel W ^a   Strunk, T ^a   Hartel C ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

CARS; IL 10; Neonates; SIRS; TGF

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; RECOMBINANT INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMATURITY; IMMUNOMODULATION; IMMUNOSTIMULATION; INFECTION COMPLICATION; LYMPHOCYTE; NEWBORN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0347319052     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02313.x     Document Type: Article

References (51)

1. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD. Increased activity of interleukin-6 but not tumor necrosis factor-a in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994; 36:244-52.
2. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, Minoo P, DeLemos RA. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39:966-75.
3. Yoon BH, Romero R, Yang SH, Jun JK, Kim IO, Choi JH, Syn HC. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996; 174:1433-40.
4. Kilpatrick L, Harris MC. Cytokines and the inflammatory response. In: Polin RA, Fox WW, eds. Fetal and Neonatal Physiology. Philadelphia: W.B. Saunders. 1997:1967-78.
5. Pillay V, Savage N, Laburn H. Circulating cytokine concentrations and cytokine production by monocytes from newborn babies and adults. Pflugers Arch 1994; 428:197-201.
6. Rowen JL, Smith CW, Edwards MS. Group B Streptococci elicit Leukotriene B4 and Interleukin-8 from human monocytes: neonates exhibit a diminished response. J Infect Dis 1995; 172:420-6.
7. Schibler KR, Liechty KW, White WL, Rothstein G, Christensen RD. Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host defense deficiencies of neonates. Pediatr Res 1992; 31:18-21.
8. Schibler KR, Trautman MS, Liechty KW, White WL, Rothstein G, Christensen RD. Diminished transcription of interleukin-8 by monocytes from preterm neonates. J Leukoc Biol 1993; 53:399-403.
9. Yachie A, Takano N, Ohta K, Uehara T, Fujita SI, Miyawaki T, Taniguchi N. Defective production of interleukin-6 in very small premature infants in response to bacterial pathogens. Infect Immun 1992; 60:749-53.
10. Berner R, Niemeyer CM, Leititis JU, Funke A, Schwab C, Rau U, Richter K, Tawfeek MS, Clad A, Brandis M. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 1998; 44:469-77.
11. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179:194-202.
12. Kashlan F, Smulian J, Shen-Schwarz S, Anwar M, Hiatt M, Hegyi T. Umbilical vein interleukin-6 and tumor necrosis factor alpha plasma concentrations in the very preterm infant. Pediatr Infect Dis J 2000; 19:238-43.
13. Schultz C, Rott C, Temming P, Schlenke P, Möller JC, Bucsky P. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 2002; 51:317-22.
14. Schultz C, Temming P, Gembruch U, Strunk T, Bucsky P. Polyclonal intravenous immunoglobulin to prevent brain injury in preterm infants. Lancet 2002; 359:1522-4.
15. Bone RC, Grodzin CJ, Balk RA. Sepsis, a new hypothesis for pathogenesis of the disease process. Chest 1997; 112:235-43.
16. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997; 42:1-8.
17. Dammann O, Leviton A. Brain damage in preterm newborns might enhancement of developmentally regulated endogenous protection open a door for prevention? Pediatrics 1999; 104:541-50.
18. Sáez-Llorens X, McCracken GH. Sepsis syndrome and septic shock in pediatrics: current concepts of terminology, pathophysiology, and management. J Pediatr 1993; 123:497-508.
19. Powell KR. Sepsis and shock. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. Philadelphia: W.B. Saunders Company, 2000:747-51.
20. Duggan PJ, Maalouf EF, Watts TL et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet 2001; 358:1699-700.
21. Klein JO. Bacterial sepsis and meningitis. In: Remington JS, Klein JO, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia: W.B. Saunders Company, 2001:943-98.
22. LaGamma EF, Drusin LM, Mackles AW, Machalek S, Auld PAM. Neonatal infections: an important determinant of late NICU mortality in infants <1000 g at birth. Am J Dis Child 1983; 137:838-41.
23. Martinot A, Leclerc F, Cremer R, Leteurtre S, Fourier C, Hue V. Sepsis in neonates and children: definitions, epidemiology, and outcome. Pediatr Emerg Care 1997; 13:277-81.
24. Stoll BJ, Gordon T, Korones SB et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129:63-71.
25. Stoll BJ, Gordon T, Korones SB et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996; 129:72-80.
26. Schultz C, Rott C, Temming P, von Puttkamer J, Bucsky P. Influence of specimen age and use of different negative controls in determination of intracytoplasmic cytokine levels after whole-blood culture assay. Clin Diagn Laboratory Immunol 2002; 9:295-8.
27. Härtel C, Bein G, Kirchner H, Klüter H. A human whole-blood assay for analysis of T-cell function by quantification of cytokine mRNA. Scand J Immunol 1999; 49:649-54.
28. Schultz C. Intracytoplasmic detection of proinflammatory cytokines and chemokines in monocytes by flow cytometry. In: Körholz D, Kiess W, eds. Cytokines and Colony Stimulating Factors, Methods and Protocols - Part II. Detection Assays for Cytokines and Growth Factors. Methods in Molecular Biology. New Jersey: Humana Press, 2002:29-39.
29. Bogdan C, Nathan C. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann NY Acad Sci 1993; 685:713-39.
30. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16:137-61.
31. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
32. Derkx B, Marchant A, Goldman M, Bijlmer R, van Deventer S. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis 1995; 171:229-32.
33. Doughty L, Carcillo JA, Kaplan S, Janosky J. The compensatory anti-inflammatory cytokine interleukin-10 response in pediatric sepsis-induced multiple organ failure. Chest 1998; 113:1625-31.
34. Hatherill M, Tibby SM, Turner C, Ratnavel N, Murdoch IA. Procalcitonin and cytokine levels: relationship to organ failure and mortality in pediatric septic shock. Crit Care Med 2000; 28:2591-4.
35. Romagnoli C, Frezza S, Cingolani A et al. Plasma levels of interleukin-6 and interleukin-10 in preterm neonates evaluated for sepsis. Eur J Pediatr 2001; 160:345-50.
36. Rainsford E, Reen DJ. Interleukin-10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol 2002; 116:702-9.
37. Trivedi HN, HayGlass KT, Gangur V, Allardice JG, Embree JE, Plummer FA. Analysis of neonatal T cell and antigen presenting cell functions. Hum Immunol 1997; 57:69-79.
38. Chheda S, Palkowetz KH, Garofalo R, Rassin DK, Goldman AS. Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor-α and its receptors. Pediatr Res 1996; 40:475-83.
39. Kotiranta-Ainamo A, Rautonen J, Rautonen N. Interleukin-10 production by cord blood mononuclear cells. Pediatr Res 1997; 41:110-3.
40. Härtel C, Bein G, Müller-Steinhardt M, Klüter H. Ex vivo induction of cytokine mRNA expression in human blood samples. J Immunol Meth 2001; 249:63-71.
41. Andrews T, Zhang P, Bhat NR. TNF-α potentiates IFN-γ-induced cell death in oligodendrocyte progenitors. J Neurosci Res 1998; 54:574-83.
42. Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 1994; 14:846-56.
43. Brett FM, Mizisin AP, Powell HC, Campbell IL. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol 1995; 54:766-75.
44. DeVries HE, Blom-Roosemalen MC, VanOsten M, DeBoer AG, VanBerkel TJ, Breimer DD, Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 1996; 64:37-43.
45. Yoon BH, Romero R, Kim CJ, Koo JN, Choe G, Syn HC, Chi JG. High expression of tumor necrosis factor-α and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol, 1997; 177:406-11.
46. Schultz C, Tautz J, Reiss I, Möller JC. Prolonged mechanical ventilation induces pulmonary inflammation in preterm infants. Biol Neonate 2003; 84:64-6.
47. Blahnik MJ, Ramanathan R, Riley CR, Minoo P. Lipopolysaccharide-induced tumor necrosis factor-α and IL-10 production by lung macrophages from preterm and term neonates. Pediatr Res 2001; 50:726-31.
48. Froen JF, Munkeby BH, Stray-Pedersen B, Saugstad OD. Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation on perinatal cerebral hypoxia-ischemia. Pediatr Res 2002; 52:790 (Abstract. 70).
49. Chernoff AE, Granowitz EV, Shapiro L et al. A randomised, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. J Immunol 1995; 154:5492-9.
50. Kumar A, Creery WD. The therapeutic potential of interleukin-10 in infection and inflammation. Arch Immunol Ther Exp 2000; 48:529-38.
51. Fisher CJ, Dhainaut JA, Opal SM et al. Recombinant human interleukin-1 receptor antagonist in the treatment of patients with sepsis. J Am Med Assoc 1994; 271:1836-43.